Clinical trial
Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder…
NCT00147394 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00147394 |
|---|---|
| Title | Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD) |
| Official title | Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Child Development Disorders, Pervasive |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 100 |
| Start date | Dec 1, 2001 |
| Completion | Jun 1, 2004 |
| First posted | Sep 7, 2005 |
| Last update posted | Oct 29, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: